Maximum quantity allowed is 999
Please select the quantity
CAS RN: 159857-80-4 | Product Number: M3224
MC-Val-Cit-PAB-OH
×
![]()
×
Purity: >98.0%(HPLC)(N)
Synonyms:
- N-[6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-N5-carbamoyl-N-[4-(hydroxymethyl)phenyl]-L-ornithinamide
- 6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-[(S)-1-[[(S)-1-[[4-(hydroxymethyl)phenyl]amino]-1-oxo-5-ureidopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]hexanamide
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 100MG |
$191.00
|
11 | 0 | Contact Us | |
| 500MG |
$669.00
|
5 | 21 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | M3224 |
| Purity / Analysis Method | >98.0%(HPLC)(N) |
| Molecular Formula / Molecular Weight | C__2__8H__4__0N__6O__7 = 572.66 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (-20°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Light Sensitive,Moisture Sensitive,Heat Sensitive |
| Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 159857-80-4 |
| Reaxys Registry Number | 15438807 |
| PubChem Substance ID | 468592347 |
| MDL Number | MFCD26142966 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(with Total Nitrogen) | min. 98.0 % |
Properties (reference)
GHS
Related Laws:
Transport Information:
| H.S.code* | 2925.19-000 |
Application
A Peptide Linker Designed for Antibody-Drug Conjugate (ADC)
This product is a peptide linker designed for Antibody-Drug Conjugate (ADC) which concept is to use an antibody to deliver a cytotoxic drug (payload) selectively to a target such as a tumor-associated antigen.
References
- Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity
- Antibody-Drug Conjugates for Cancer Therapy
- Design, Synthesis, and Biological Evaluation of Antibody-Drug Conjugates Comprised of Potent Camptothecin Analogues
Articles/Brochures
TCIMAIL
[Featured Products] Enzymatically Cleavable Linkers for Antibody-Drug Conjugates (ADCs)[TCIMAIL No.183] Dipeptides Degradable by Enzyme in Lysosome
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.